Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 36,589 $ 224,721
Restricted cash, current 3,426 2,771
Inventory 2,954 0
Prepaids and other current assets 9,350 63,814
Total current assets 52,319 291,306
Property and equipment, net 311,400 202,314
Restricted cash, non-current 10,600 0
Operating lease right-of-use assets 39,331 14,228
Deferred warrant asset 50,175 0
Deferred battery supplier cost 30,000 11,700
Other non-current assets 2,647 3,526
Total assets 496,472 523,074
Current liabilities    
Accounts payable 103,187 52,267
Accrued expenses and other current liabilities 63,091 83,925
Convertible debt 34,829 0
Warrant liability 17,171 0
Total current liabilities 218,278 136,192
Contingent earnout shares liability 3,013 29,057
Operating lease liabilities 38,608 13,826
Total liabilities 259,899 179,075
Commitments and contingencies (Note 12)
Stockholders’ equity    
Preferred stock, $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding as of December 31, 2022 and 2021 0 0
Common stock, $0.0001 par value; 500,000 shares authorized; 355,388 and 238,578 issued and outstanding as of December 31, 2022 and 2021, respectively 35 24
Additional paid-in capital 1,416,361 1,036,104
Accumulated deficit (1,179,823) (692,129)
Total stockholders’ equity 236,573 343,999
Total liabilities and stockholders’ equity $ 496,472 $ 523,074